Common questions about Durela (FAQ)
Q: If I miss a dose of Durela, what do official instructions say I should do?
Official drug labels state that Durela should be taken once daily at approximately the same time every day. General instructions for extended-release opioids advise taking the missed dose only if there is still enough time until the next scheduled dose. Regulatory warnings state that taking two doses at once should be avoided due to the risk of accidental overdose.
Q: Is it true that Durela can cause weight changes?
Weight changes are not typically listed among the most commonly (Very Common or Common) reported side effects in the regulatory documents for Tramadol Extended-Release. Regulatory documents advise that any concerns about physical changes, including weight, should be addressed with a prescribing healthcare professional.
Q: Can Durela be taken with common over-the-counter pain relievers?
Regulatory documents primarily focus warnings on interactions with CNS depressants, serotonergic agents, and specific enzyme inhibitors. There are generally no stated contraindications against using Durela with common over-the-counter pain relievers like acetaminophen or ibuprofen. The consideration of all drug combinations, including over-the-counter products, is typically managed by a prescribing healthcare professional.
Q: Are there any known interactions between Durela and common vitamin supplements?
While specific vitamins may not have explicit warnings, the official literature requires that patients inform their doctor of all medications, including vitamins and herbal products. This is especially important because certain herbal remedies, such as St. John's wort, can increase the risk of serious side effects like Serotonin Syndrome when combined with Durela.
Q: What should be done if a severe side effect from Durela occurs?
Patient information leaflets describe serious adverse reactions that require immediate emergency medical attention. These rare but critical signs include symptoms like slow or shallow breathing, severe dizziness, confusion, or a seizure (convulsion). Official documentation states that these signs require immediate emergency medical attention.
Q: Does official guidance state that Durela can affect sleep patterns?
Yes, official documents list somnolence (drowsiness) as a common side effect, which can affect a person's wakefulness. In addition, some regulatory summaries note that sleep disturbances, including difficulty sleeping (insomnia), have been reported in patients taking the medicine.
Q: How does the official literature describe the long-term safety of Durela?
The official literature notes that most controlled clinical trials for the extended-release form were short-term, typically 12 weeks or less, meaning there is limited long-term data on sustained efficacy. The risk of addiction, abuse, and misuse is documented to persist throughout the course of long-term therapy, and the regulatory profile indicates that periodic reassessment is an essential component of the long-term management strategy.
Q: What is the official information regarding Durela use during pregnancy?
Official information states that prolonged use of Durela during pregnancy is not recommended. This is because it may result in Neonatal Opioid Withdrawal Syndrome (NOWS), which is a potentially serious condition for the newborn after birth.
Q: Do any official warnings exist about stopping Durela suddenly?
Yes, official warnings state that Durela should not be rapidly reduced or abruptly discontinued in a physically dependent patient. Stopping suddenly can result in serious opioid withdrawal symptoms and an uncontrolled return of pain. Because of this risk, official guidance describes the necessity of gradual dose reduction when discontinuing the medication.
Q: What is the relationship between Durela and liver function?
Tramadol, the active ingredient, is processed by the liver. Official labeling notes that Durela is generally not recommended for patients with severe hepatic impairment (serious liver damage) due to the difficulty of adjusting the dose appropriately with the extended-release capsule form.
Q: What exactly does the label 'Schedule X' mean for Durela?
Durela, containing Tramadol, is classified as a Schedule IV controlled substance in the United States. This legal classification indicates that the drug has an accepted medical use but still has a lower potential for abuse and dependence compared to substances in Schedules I, II, or III.
Q: Are there different brand names for the same medicine as Durela?
Yes, Durela is a brand name for Tramadol Hydrochloride Extended-Release. The active ingredient, Tramadol, is widely available under numerous other brand names and as a generic product in both immediate-release and extended-release forms globally.
Q: Is Durela available in different dosage forms (e.g., tablet, liquid)?
Durela is specifically manufactured and marketed as an Extended-Release Capsule. While the active ingredient, Tramadol, is available in other formulations like immediate-release tablets or oral solutions, these are generally not sold under the Durela brand name.
Q: Is a generic version of Durela available on the market?
Yes. The active ingredient in Durela, Tramadol Hydrochloride Extended-Release, is available in generic versions. These generic formulations are considered therapeutically equivalent to the brand-name product.
Q: Can Durela affect laboratory test results?
Tramadol is generally not included in standard 5 or 10-panel drug tests. However, it can be detected by specialized or advanced screening panels, which may be relevant for specific regulatory or monitoring programs that check for opioids.
Q: Is Durela often prescribed alongside other medicines?
Durela is approved to relieve pain in people who are expected to need consistent opioid treatment. In the management of chronic pain, it is common for this medication to be prescribed as part of a combination therapy that may involve non-opioid medications.
Q: Is Durela known to cause problems with eyesight?
Official adverse reaction lists note that vision abnormalities, including blurred vision, have been reported in patients taking the medication. These effects are generally listed in the Uncommon or Rare frequency categories.
Q: Are there different instructions for taking Durela depending on the time of day?
Official instructions specify taking Durela once daily at approximately the same time every day to maintain consistent blood levels. There is no restriction on taking it specifically in the morning or evening, as long as the timing is consistent.
Q: Is Durela covered by most national drug formularies?
Formulary status for Durela (Tramadol ER) varies widely by insurance plan and national healthcare system. Many formularies include it, but the coverage often involves specific tier placement or local prior authorization requirements that must be met.
Q: What does the term 'contraindication' mean in the context of Durela?
A contraindication is a symptom or medical condition that serves as a reason for a treatment to not be used because it could be harmful. For Durela, absolute contraindications include severe respiratory depression or concurrent use with MAOI medications.
Q: Is the active ingredient in Durela also used in any other products?
Yes. Tramadol Hydrochloride, the active ingredient in Durela, is also used in numerous other medicinal products. These include immediate-release tablets and combination products, such as those that combine tramadol with acetaminophen.
Q: Can people who are allergic to certain inactive ingredients still take Durela?
The official patient information indicates that information regarding all known allergies, including allergies to non-active components, should be shared with a healthcare professional. This is because Durela contains inactive ingredients that could potentially cause allergic reactions or other problems in susceptible individuals.
Q: Are there any specific lifestyle changes recommended while on Durela?
Official warnings strongly advise against the consumption of alcohol while taking Durela due to the significantly increased risk of serious side effects. Due to the risk of somnolence (drowsiness), regulatory documents contain warnings about operating hazardous machinery until the full effect of the medication is known.
Q: What is the maximum duration for which Durela has been studied in clinical trials?
While the FDA states many controlled trials were short-term (12 weeks or less), some controlled studies investigating the long-term use of extended-release tramadol formulations have been conducted for periods up to six months.
Q: Are there specific official guidelines for Durela use in adolescents?
Official guidance strictly contraindicates Durela use in children younger than 12 years of age. Its use is also avoided in adolescents aged 12 to 18 who have specific risk factors for breathing problems, such as obstructive sleep apnea, as documented in official drug safety communications.
Q: Does Durela have different names in other countries?
Yes. Although the brand name Durela may be specific to one market, Tramadol extended-release is sold globally under numerous different brand names, depending on the country and the manufacturer.
Q: Is Durela known to cause changes in mood or behavior?
Official warnings note that Durela may cause some people to become agitated, irritable, or display other abnormal behaviors. It is also mentioned that it may be associated with serious psychological symptoms, including suicidal thoughts or tendencies, in some patients.
Q: What kind of studies have been performed on Durela?
The primary evidence supporting Durela's use is drawn from short-term, randomized, controlled trials (RCTs). These studies compared Durela against placebo for management of conditions like chronic low back pain and osteoarthritis pain.
Q: Is there an official patient information leaflet available for Durela?
Yes. As a prescription opioid, Durela is required to be dispensed with an FDA-mandated Medication Guide, often referred to as a Patient Information Leaflet. This guide provides crucial safety information and warnings to the patient.
Q: What are the official guidelines about drinking alcohol while on Durela?
Official regulatory warnings advise against the use of alcohol while taking Durela. Combining the two significantly increases the risk of profound sedation, severe respiratory depression (breathing problems), coma, and death.
